$FIGS

FIGS Stock Soars After Earnings Beat And Upgraded Outlook

FIGS Inc. (NYSE: FIGS) shares rose about 28.7% in a week after a Q2 earnings beat and an upgraded FY26 outlook, according to the article. Q2 results included EPS $0.15 vs $0.07 and revenue up 29% to $196.6M, with gross margin 66.6% and adjusted EBITDA margin 18.6%. FY26 guidance was raised to about 20% revenue growth and 14.8% to 15% EBITDA margin.

Original reporting
Published Aug 9, 2026, 12:38 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 3:25 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FIGS Stock Soars After Earnings Beat And Upgraded Outlook — source image
Decision brief

The 30-second read

$FIGSBullishMed
01

Why it matters

Earnings beat plus raised FY26 revenue and EBITDA margin targets are presented as the core catalyst for the rerating, with technical breakout levels guiding short-term trade planning.

02

Market read

Traders get a same-week earnings-and-guidance catalyst summary tied to a large price move and specific support/resistance zones.

03

What to watch

It cites supply chain and macro risks but provides no new mitigation details; traders may need to watch whether the raised FY26 targets are credible versus prior execution.

Relevance 8/10Novelty 6/10Timing: post-earnings, same-week breakout and guidance raise

Background

The piece is a weekly update centered on FIGS’ post-earnings price action, combining fundamental results, guidance, and technical breakout levels.

Company-level read

Ticker impact

$FIGSBullishMedium confidence
Context

FIGS shares are up ~28.7% after the article cites a Q2 EPS beat ($0.15 vs $0.07), revenue +29%, and raised FY26 guidance.

Expected impact

Near-term momentum likely remains supported, but the article flags elevated volatility and a rich valuation that can amplify pullbacks if growth or margins wobble.

Evidence & confidence

The article provides specific earnings and guidance numbers plus technical breakout levels, but it does not add verifiable new primary disclosures beyond the earnings/guidance narrative.

Market effects

Supports the narrative that profitable growth in consumer healthcare apparel can command premium multiples versus apparel peers.

No specific regional linkage beyond US-listed momentum in consumer discretionary.

Limited; the catalysts described are company-specific earnings and guidance.

Counterpoint

The article highlights a high P/E (~68) and valuation risk, so the move could be vulnerable to any deceleration in revenue growth or margin compression.

Key entities

  • FIGS Inc.

    US-listed healthcare apparel retailer whose Q2 results and raised FY26 guidance are cited as the catalyst for a sharp stock move.

Related articles

$FIGSHighAI 9/10

FIGS (FIGS) Q2 2026 Earnings Call Transcript

FIGS, Inc. (FIGS) reported Q2 2026 net revenues of $196.6 million, up 28.8%, driven by higher order volume and record average order values. Scrubwear revenue rose 26.5% to $161.2 million. Gross margin was 75.2% and net income $28.4 million. The company raised FY2026 net revenue guidance to about 20% growth and EBITDA margin to 14.8% to 15.0%.

$FIGSHighAI 9/10

FIGS Q2 Earnings Call Highlights

FIGS (NYSE:FIGS) reported Q2 results and an earnings call update. International revenue rose 67% to $37.9M and U.S. revenue grew 22% to $158.7M. Gross margin increased to 75.2% with a $15.4M tariff refund benefit. Net income was $28.4M, or $0.15/share. FIGS raised FY2026 revenue growth to ~20% and operating margin to ~10.8%, and repurchased about $24M of shares.

$FIGSHighAI 9/10

FIGS Stock Jumped 27% on Its Q2 Beat. The Raised Guide Did the Real Work.

FIGS (FIGS) shares rose about 27% on Aug. 7 after Q2 results beat estimates and management raised full-year guidance. Q2 revenue was $196.6M (+29% YoY) and EPS was $0.15 vs $0.07 consensus. Gross margin hit 75.2% but included a one-time tariff refund; core margin improved. Full-year growth guidance lifted to ~20% from 14% to 16%, plus a $100M buyback authorization.

$FIGSMedAI 8/10

FIGS, Inc. Lifts Outlook Amid Robust Growth

FIGS, Inc. (FIGS) reported Q2 results and lifted full-year revenue growth guidance to about 20%. Net revenues rose 29% to $196.6M, with gross margin up 820 bps to 75.2% and operating margin to 17.9%. Management cited $20.5M tariff refunds and raised 2026 operating margin and adjusted EBITDA outlooks, while noting Q3 margin pressure from a Jordan import hold and airfreight.

$FIGSHighAI 8/10

Why Figs Stock Popped Today

Figs (NYSE: FIGS) shares rose after the medical apparel company reported Q2 results above expectations. Net revenue increased 28.8% to $196.6 million, with active customers up 13.2% to 3.1 million. Gross margin rose to 75.2% and net income rose to $28.4 million, or $0.15 per share. Figs raised its 2026 revenue growth outlook to about 20% and increased its buyback by $100 million.

$FIGSMedAI 8/10

Why Is Figs (FIGS) Stock Soaring Today

Figs (NYSE: FIGS) shares rose about 28.5% after the company reported Q2 2026 results that beat Wall Street on revenue and adjusted EPS. Active customers increased 13% to 3.1 million, average order value rose to $127, adjusted EPS was $0.11 vs $0.07 consensus, and operating margin widened to 17.9% from 6.5%. The board raised its buyback authorization and FCF turned positive.